Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Levitra is effective in men of diverse ethnic origin

Aug. 11, 2003

Collaborative Study Group to conduct KRX-101 phase II/III program

Aug. 7, 2003

Sustained symptom relief induced by tamsulosin in BPH

Aug. 1, 2003

Enrollment completed in phase IIb at-home study of PT-141

July 29, 2003

Preclinical evaluation of A-350619: a potential novel treatment for sexual dysfunction

July 24, 2003

Erectile function and treatment satisfaction best following penile implant surgery

July 24, 2003

New M3-selective muscarinic antagonists and their use described by Spanish scientists

July 23, 2003

VR-004 shows efficacy in phase IIa erectile dysfunction trial

July 23, 2003

At-home study of TA-1790 opens enrollment

July 22, 2003

Disappointing results for proof-of concept trial of VI-0162 in PE

July 21, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...